COMMUNIQUÉS West-GlobeNewswire

Targovax ASA: Protocol from the Annual General Meeting
11/04/2018
The annual general meeting was held on April 11, 2018 at the Company's offices at Lilleakerveien 2C, 0283 Oslo. Please find minutes of the meeting attached. For further information, please contact: Renate Birkeli, [...]
Inivata: Presentation of New Data on Inivata's Industry-Leading Liquid Biopsy Platform at AACR 2018 Annual Meeting
11/04/2018
Presentation of New Data on Inivata's Industry-Leading Liquid Biopsy Platform at AACR 2018 Annual Meeting Oral presentations and posters to feature Inivata's InVision® liquid biopsy platform and its application Research [...]
Curetis Establishes U.S. Scientific Advisory Board
11/04/2018
Curetis Establishes U.S. Scientific Advisory Board U.S. Scientific Advisory Board formed with five renowned infectious disease specialists Expands Curetis' scientific network and clinical expertise to support U.S. [...]
Enzymatica AB: New results from Enzymatica's in vitro study: ColdZyme also deactivates corona virus
11/04/2018
Press Release April 11, 2018 New results from Enzymatica's in vitro study: ColdZyme also deactivates corona virus Today Enzymatica announced the results of an in vitro study demonstrating the ability of ColdZyme® Mouth [...]
Solon Eiendom ASA : Primary insider notification
11/04/2018
(Oslo, Norway, April 10 2018) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company Hortulan AS) has today bought 50,000 shares in Solon Eiendom ASA at a price of NOK 26.3524 per share [...]
Shire plc : Rule 2.9 Announcement
11/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 11 April 2018 [...]
07/2018 - Interim Report 1 September 2017 - 28 February 2018
11/04/2018
Company Announcement No. 07/2018 For further information, please contact: Martin Riise, Head of Investor Relations Tel: +45 53 39 22 50 Helle Rexen, Interim Head of Media Relations Tel: +45 20 74 28 40 About Chr. Hansen [...]
Verona Pharma Announces Departure of Chief Medical Officer
11/04/2018
LONDON, April 11, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma” or “the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative [...]
GENFIT: Major Milestone for the RESOLVE-IT Phase 3 Trial on the Recruitment of the Interim Analysis Cohort
11/04/2018
GENFIT: Major Milestone for the RESOLVE-IT Phase 3 Trial on the Recruitment of the Interim Analysis Cohort Recruitment of the patient cohort for accelerated approval has been reached Interim baseline data on the first 1 [...]
GENFIT : Franchissement d'une étape clé de l'étude de phase 3 RESOLVE-IT avec le recrutement de la cohorte d'analyse intermédiaire
11/04/2018
GENFIT : Franchissement d'une étape clé de l'étude de phase 3 RESOLVE-IT avec le recrutement de la cohorte d'analyse intermédiaire Le recrutement de la cohorte de patients en vue de la mise sur le marché anticipée a été [...]
ESPERITE (ESP): EUR 1,200,000 of new funding provided by European Select Growth Opportunities Fund until May 25, 2018.
11/04/2018
Continuation of support to Esperite's strategy, commercial activities and development of innovative technologies in the field of genetics and regenerative medicines Amsterdam, The Netherlands - 11 April 2018 As of today [...]
Assembly Biosciences to Host Conference Call on April 12 to Review ABI-H0731 Interim Phase 1b Data in HBV Patients Featured in Late-Breaker Poster at EASL
10/04/2018
INDIANAPOLIS and SAN FRANCISCO, April 10, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB ), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of [...]
Extendicare Announces Timing of 2018 First Quarter Results and Conference Call
10/04/2018
MARKHAM, Ontario, April 10, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) announced today that it plans to release its financial results for the first quarter of 2018, after [...]
Nextech to Explore Ways to Reduce Administrative Burden at ASCRS-ASOA Annual Symposium & Congress 2018
10/04/2018
Predictive charting functionalities among new IntelleChartPRO features highlighted at the show TAMPA, Fla., April 10, 2018 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of health care technology solutions for [...]
Avivagen Announces Results from Its Annual General Meeting
10/04/2018
OTTAWA, April 10, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, [...]
Analogic to Be Acquired by an Affiliate of Altaris Capital Partners for $84.00 per Share or $1.1 Billion in Cash
10/04/2018
Comprehensive Alternatives Review Process to Maximize Stockholder Value Culminates in Strategic Transaction Represents 25% Premium to Analogic’s Stock Price of $67.45 as of June 7, 2017, the Day Following Analogic’s [...]
OraSure Technologies Appoints New Senior Vice President, Business Development
10/04/2018
BETHLEHEM, Pa., April 10, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced that David Rappaport has been [...]
TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
10/04/2018
REGULATED INFORMATION PRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - April 10, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") [...]
Brain Armor Announces Distribution at Walmart Inc.
10/04/2018
Brookfield, WI , April 10, 2018 (GLOBE NEWSWIRE) -- Brain Armor Inc., an innovative nutrition company dedicated to improving cognitive health and performance on every field of play and a subsidiary of Trident Brands, [...]

Pages